Franklin M. Berger - 21 Sep 2021 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-fact
Issuer symbol
KZR
Transactions as of
21 Sep 2021
Net transactions value
+$170,269
Form type
4
Filing time
23 Sep 2021, 16:26:30 UTC
Previous filing
30 Jun 2021
Next filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KZR Common Stock Options Exercise $52,575 +8,896 +1.1% $5.91 792,899 21 Sep 2021 Direct
transaction KZR Common Stock Options Exercise $67,876 +8,896 +1.1% $7.63 801,795 21 Sep 2021 Direct
transaction KZR Common Stock Options Exercise $49,818 +8,896 +1.1% $5.60 810,691 22 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Stock Option (Right to Buy) Options Exercise $0 -8,896 -100% $0.000000* 0 21 Sep 2021 Common Stock 8,896 $5.91 Direct F1
transaction KZR Stock Option (Right to Buy) Options Exercise $0 -8,896 -100% $0.000000* 0 21 Sep 2021 Common Stock 8,896 $7.63 Direct F2
transaction KZR Stock Option (Right to Buy) Options Exercise $0 -8,896 -100% $0.000000* 0 22 Sep 2021 Common Stock 8,896 $5.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-hundred percent (100%) of the shares subject to the option vested on 1/1/2019.
F2 One-hundred percent (100%) of the shares subject to the option vested on 6/25/2020.
F3 One-hundred percent (100%) of the shares subject to the option vested on 6/24/2021.